PKI-166


CAS No. : 187724-61-4

187724-61-4
Price and Availability of CAS No. : 187724-61-4
Size Price Stock
5mg $150 In-stock
10mg $225 In-stock
25mg $400 In-stock
50mg $600 In-stock
100mg $960 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-117155
M.Wt: 330.38
Formula: C20H18N4O
Purity: >98 %
Solubility: DMSO : ≥ 125 mg/mL
Introduction of 187724-61-4 :

PKI-166 is a potent, selective and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 0.7 nM[1]. IC50 & Target: IC50: 0.7 nM (EGFR tyrosine kinase)[1] In Vitro: Pretreatment with PKI-166 (0-0.5 μM; 1 hour) inhibits EGFR autophosphorylation in human pancreatic cancer cells[1].
PKI-166 (0.03μ M; 6 days) enhanced the cytotoxicity mediated by gemcitabine[1].
In Vivo: PKI-166 (100 mg/kg; p.o.; daily; day 7-day 35 after xenograft) inhibits of pancreatic cancer growth[1].

Your information is safe with us.